Transfusion Surveillance in Anaesthesia
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Transfusion.
- Who it may be relevant to
- Registry conditions: Transfusion Reaction, Transfusion Related Complication, Anesthesia, Anesthesia; Shock. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Belgium
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Biological Transfusion Efficiency Registry Transfusion Surveillance in Anaesthesia
Overview
the aim of this register is to collect exhaustively the different data available surrounding a transfusion act in the context of an active haemorrhage. The aim is to allow different modelling and analysis related to emergency transfusion.
Detailed description
the aim of this register is to collect exhaustively the different data available surrounding a transfusion act in the context of an active haemorrhage. The aim is to allow different modelling and analysis related to emergency transfusion.
Patients will be informed at the time of the anaesthesia consultation about the inclusion in the registry.
The data will be collected from the patients' files by the investigators of the centre without modifying their management.
The data collection period will not exceed the period of acute management.
Interventions
- Procedure Transfusion
Transfusion of an hemostatic product
Primary outcome measures
- Hemostatic evolution through transfusion event [Time frame: 12 hours]
- ROTEM measures evolution through transfusion event [Time frame: 12 hours]
- Haematologic measures evolution through transfusion event [Time frame: 12 hours]
- ionic measures evolution through transfusion event [Time frame: 12 hours]
Secondary outcome measures (1)
- Mortality at one month [Time frame: one month]
Eligibility criteria
Inclusion criteria
- all patients who have received an hemostasis product
Exclusion criteria
- patient who refused to consent to data analysis and study participation
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Belgium · 1 center
- Université libre de Bruxelles — Anderlecht
Identifiers
NCT: NCT06403163 · STAR